Last week, Tweed, Inc., which is set to become Canopy Growth Corp following its acquisition of Bedrocan Cannabis, issued its annual report for the year ending March 31, 2015. The company, the first licensed producer under Canada’s medical marijuana program to trade publicly (TWD on the TSX Venture, but changing to CGC), discussed the first year in the creation of its global medical marijuana brand:
This is the first and potentially the last annual review for Tweed Marijuana Inc. (TMI). The Company is entering an era of expansion, through acquisition but also through global market exploration. In the future, TMI may transition from a parent company with two licensed subsidiaries to a multinational holding company operating a number of brands in a number of countries around the world.
The initial year of public operations was dedicated to building a foundation rooted in the Canadian market regulated by the MMPR. Other countries are looking at Canada as the global leader in medical cannabis policy. Canada is the best incubator for a global cannabis company because Canadian regulations have been designed with scalability and distribution in mind.
The report includes a message from CEO Bruce Linton, a discussion of the industry and environment, a review of the company’s operations, a description of its customer base, an explanation of its diversification strategy, a review of its success in the capital markets, details of its patient and community outreach, a statement of company goals and a presentation of financial highlights.
Bruce Linton, CEO of Canopy Growth Corp
We are proud of what we were able to accomplish in a short period of time and welcome the challenges and prosperity that lie ahead.
Download the Tweed FY15 Annual Report
